Uni-Bio Science Group Limited has filed a New Drug Application with the CFDA for China approval of Uni-PTH, the company's proprietary treatment for osteoporosis. Uni-PTH is a 34 amino acid analogue of parathyroid hormone (PTH) that controls the level of calcium and phosphorus in the blood and vitamin D in the kidney. Founded in 2001, Uni-Bio is headquartered in Hong Kong with operations in China. The CFDA has accepted the application.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
